MFDS — authorised 26 April 2022
- Marketing authorisation holder: MYCOVIA PHARMACEUTICALS INC
- Status: likely_approved
🇰🇷 Vivjoa in South Korea
MFDS authorised Vivjoa on 26 April 2022
Marketing authorisation
Vivjoa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Vivjoa approved in South Korea?
Yes. MFDS authorised it on 26 April 2022.
Who is the marketing authorisation holder for Vivjoa in South Korea?
MYCOVIA PHARMACEUTICALS INC holds the South Korean marketing authorisation.